Previous Page  6 / 6
Information
Show Menu
Previous Page 6 / 6
Page Background

allied

academies

Page 17

Notes:

Journal of Diabetology | Volume 3

May 16-17, 2019 | Prague, Czech Republic

Diabetes and Endocrinology

27

th

International Conference on

J Diabetol, Volume 3

T

here is growing evidence of long-term remission

of type 2 diabetes after metabolic surgery (bariatric

surgery) however; the pathophysiology of improved glucose

metabolism after surgery remains poorly understood.

Bile acids are the main component of human bile and

have traditionally been considered mediators of lipid

absorption and cholesterol metabolism, facilitated by

their amphipathic nature. In recent years bile acids have

been identified as metabolic molecules which regulate

glycaemic control amongst other processes via activating

the nuclear receptor, farnesoid X receptor (FXR) and the G

protein-coupled membrane receptor (TGR5). Furthermore

the interplay between bile acids and incretin hormones

such as glucagon like peptite-1 (GLP-1) has given us new

insight into their collective contribution in improving

glycaemic control. Bile acid pool and composition are

altered following certain metabolic surgeries such as

Roux-en-Y gastric bypass (RYGB) and the post-prandial

GLP-1 responses are enhanced after RYGB. This session

will review our current understanding of these metabolic

regulators and the potential role they play in the remission

of type 2 diabetes mellitus after metabolic surgery.

Speaker Biography

RoyceVincent isaconsultantchemicalpathologistatKing’sCollegeHospital

NHS Foundation Trust and an Honorary Senior Lecturer at King’s College

London, UK. He has a special interest in nutrition and endocrinology and

is the clinical lead for biochemistry and parenteral nutrition services. He

obtained hisMD (Res) at Imperial College London and his research interests

are in obesity, endocrinology and clinical nutrition. He has published

multiple original and review articles and is serving as an international

editorial board member for Translational Metabolic Syndrome Research.

e:

royce.vincent@nhs.net

Royce Vincent

King’s College Hospital NHS Foundation Trust, United Kingdom

Remission of type 2 diabetes mellitus: Bile acid signalling and

incretins